pyrithione has been researched along with imatinib mesylate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carter, BZ; Chen, J; Chen, X; Huang, H; Lan, X; Liu, J; Long, H; Shi, X; Wang, X; Wu, J; Yang, L; Zang, D; Zhang, P; Zhao, C | 1 |
1 other study(ies) available for pyrithione and imatinib mesylate
Article | Year |
---|---|
Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms.
Topics: Apoptosis; Caspases; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Heterografts; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nickel; Proteasome Inhibitors; Pyridines; Thiones | 2016 |